General MedicationsINTRAPLEURALStandard
SCLEROSOL
TALC
Standard Dose
4GM/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview SCLEROSOL is listed in Drugs@FDA under application 020587 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient TALC Form and strength AEROSOL;INTRAPLEURAL - 4GM/SPRAY Sponsor SCIARRA LABS Submission history Latest submission status date: 2012-10-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview SCLEROSOL is listed in Drugs@FDA under application 020587 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient TALC Form and strength AEROSOL;INTRAPLEURAL - 4GM/SPRAY Sponsor SCIARRA LABS Submission history Latest submission status date: 2012-10-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.